Bevacizumab’s Role in Recurrent Ovarian Cancer
6 Views
administrator
07/01/23
Expert perspectives on bevacizumab’s role in recurrent ovarian cancer, particularly in light of recent PARP inhibitor strategies.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
Show more
Facebook Comments
No comments found